Dr. Kooragayala is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
895 Canton Rd Ne
Building 100
Marietta, GA 30060Phone+1 770-427-8111Fax+1 770-499-1643
Education & Training
Louisiana State University School of Medicine (New Orleans)Residency, Ophthalmology, 1999 - 2002
Louisiana State University (Shreveport)Residency, Ophthalmology, 1993 - 1996
Lincoln Medical and Mental Health CenterInternship, Internal Medicine, 1992 - 1993
Kakatiya Medical College NTRClass of 1985
Certifications & Licensure
GA State Medical License 2005 - 2025
KS State Medical License 1994 - 2025
LA State Medical License 1996 - 2008- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2013
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- Ocriplasmin Research to Better Inform Treatment (ORBIT) Start of enrollment: 2014 May 01
- A Retrospective Chart Review of Patients Treated With Ocriplasmin for Symptomatic VMA Start of enrollment: 2014 Aug 01
Publications & Presentations
PubMed
- 46 citationsSurface calreticulin mediates muramyl dipeptide induced apoptosis in RK13 cellsDequan Chen, Donald E. Texada, Christopher Duggan, Chanping Liang, Thomas B. Reden
The Journal of Biological Chemistry. 2005-06-10 - 5 citationsImmunogenicity of enterovirus 70 capsid protein VP1 and its non-overlapping N- and C-terminal fragments.Dequan Chen, Chris Duggan, Donald E. Texada, Thomas B. Reden, Lakshmana M. Kooragayala
Antiviral Research. 2005-06-01 - 9 citationsExpression of enterovirus 70 capsid protein VP1 in Escherichia coli.Dequan Chen, Chris Duggan, J.P. Ganley, Lakshmana M. Kooragayala, Tomas B. Reden
Protein Expression and Purification. 2004-10-01
Press Mentions
Effect of Initial Management with Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients with Diabetic Macular Edema Involving the Center of the Macula and Good Visual AcuityMay 1st, 2019
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
